Eli Lilly Says Olomorasib Shows Durable Efficacy in Lung Cancer Studies
Eli Lilly said new trial data showed olomorasib had durable efficacy in non-small cell lung cancer studies.
Eli Lilly said new trial data showed olomorasib had durable efficacy in non-small cell lung cancer studies.